We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

44 hedge funds and large institutions have $3.1M invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

2% more funds holding

Funds holding: 43 → 44 (+1)

19% less capital invested

Capital invested by funds: $3.83M → $3.1M (-$724K)

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$191K
2
Citadel Advisors
Citadel Advisors
Florida
+$108K
3
RJA
Raymond James & Associates
Florida
+$17.1K
4
TSS
Two Sigma Securities
New York
+$8.98K
5
Renaissance Technologies
Renaissance Technologies
New York
+$8.32K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$465K
2
Goldman Sachs
Goldman Sachs
New York
-$95.6K
3
Millennium Management
Millennium Management
New York
-$55.8K
4
VKH
Virtu KCG Holdings
New York
-$26.5K
5
BRWA
B. Riley Wealth Advisors
Florida
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
26
Cambridge Investment Research Advisors
Iowa
$6K – – –
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$6K +$205 +499 +3%
BA
28
BlackRock Advisors
Delaware
$5K – – –
FCI
29
Financial Counselors Inc
Kansas
$5K – – –
EC
30
Estate Counselors
Wisconsin
$4K – – –
FAAS
31
First Allied Advisory Services
California
$4K – – –
PCM
32
Princeton Capital Management
New Jersey
$4K – – –
FWM
33
Focused Wealth Management
New York
$1K – – –
GT
34
Glenmede Trust
Pennsylvania
$1K – – –
LTFS
35
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Citigroup
36
Citigroup
New York
$1K +$346 +840 +39%
TRCT
37
Tower Research Capital (TRC)
New York
$1K +$729 +1,771 +499%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$308 – – –
BRWA
39
B. Riley Wealth Advisors
Florida
– -$11K -28,000 Closed
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
– -$7K -19,161 Closed
PAG
41
Private Advisor Group
New Jersey
– -$7K -17,075 Closed
MC
42
Marcus Capital
Illinois
– -$6K -15,000 Closed
Morgan Stanley
43
Morgan Stanley
New York
– -$494 -1,200 -71%
1
2

PVCT Hedge Fund Activity: Q1 2016 in Review

44 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q1 2016, worth a combined $3.1M — down 19% from $3.83M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PVCT positions and 4 closed out — a net gain of 1 holder — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $191K. The largest seller was Sabby Management, cutting an estimated $465K.

  • 44 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q1 2016, up from 43 in Q4 2015.
  • Funds reported $3.1M of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q1 2016, down 19% quarter-over-quarter.
  • 5 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q1 2016 and 4 closed out, a net change of +1 holder.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q1 2016 was Vanguard Group, an estimated $191K added.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) seller in Q1 2016 was Sabby Management, an estimated $465K sold.

Based on aggregated 13F filings for Q1 2016.